Status:
COMPLETED
Polypharmacy in Clozapine-resistant Schizophrenia
Lead Sponsor:
Niuvanniemi Hospital
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The aim of this randomized, double-blind study is to verify the hypothesis that clozapine monotherapy is as efficient as a combination of clozapine and olanzapine therapy in treatment-resistant schizo...
Eligibility Criteria
Inclusion
- age ≥18 years, (adult), legally competent
- the patient is able to understand the purpose of the study and is eligible to sign the written informed consent form.
- insufficient response to the valid clozapine-olanzapine -polypharmacy
- psychotropic medication has been constant (unchangeable) during the past 2 months
Exclusion
- Pregnancy
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00918021
Start Date
June 1 2009
End Date
July 1 2010
Last Update
November 19 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Niuvanniemi Hospital
Kuopio, Finland, FI-70240